{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:50:07Z","timestamp":1761562207655},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10557-017-6714-5","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T01:37:54Z","timestamp":1487727474000},"page":"5-7","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Next-Generation Stem Cell Therapy: Genetically Modified Mesenchymal Stem Cells for Cardiac Repair"],"prefix":"10.1007","volume":"31","author":[{"given":"Shathiyah","family":"Kulandavelu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Balkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M.","family":"Hare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"issue":"4","key":"6714_CR1","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29\u2013322.","journal-title":"Circulation"},{"issue":"4","key":"6714_CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature Med. 2005;11(4):367\u20138.","journal-title":"Nature Med"},{"issue":"22","key":"6714_CR3","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/eurheartj\/ehp265","volume":"30","author":"KH Schuleri","year":"2009","unstructured":"Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J, et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J. 2009;30(22):2722\u201332.","journal-title":"Eur Heart J"},{"issue":"7","key":"6714_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCRESAHA.110.222703","volume":"107","author":"KE Hatzistergos","year":"2010","unstructured":"Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010;107(7):913\u201322.","journal-title":"Circ Res"},{"issue":"10","key":"6714_CR5","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jacc.2006.06.073","volume":"48","author":"LC Amado","year":"2006","unstructured":"Amado LC, Schuleri KH, Saliaris AP, Boyle AJ, Helm R, Oskouei B, et al. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol. 2006;48(10):2116\u201324.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"6714_CR6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"114","author":"V Karantalis","year":"2014","unstructured":"Karantalis V, DiFede DL, Gerstenblith G, Pham S, Symes J, Zambrano JP, et al. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the prospective randomized study of mesenchymal stem cell therapy in patients undergoing cardiac surgery (PROMETHEUS) trial. Circ Res. 2014;114(8):1302\u201310.","journal-title":"Circ Res"},{"issue":"1","key":"6714_CR7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman AW, DiFede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014;311(1):62\u201373.","journal-title":"JAMA"},{"issue":"24","key":"6714_CR8","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JM Hare","year":"2009","unstructured":"Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54(24):2277\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"6714_CR9","doi-asserted-by":"crossref","unstructured":"Hare JM, DiFede DL, Castellanos AM, Florea V, Landin AM, El-Khorazaty J et al. Randomized Comparison of Allogeneic Vs. Autologous Mesenchymal Stem Cells for Non-lschemic Dilated Cardiomyopathy: POSEIDON-DCM Trial. J Am Coll Cardiol. 2017;69(5):526\u201337.","DOI":"10.1016\/j.jacc.2016.11.009"},{"issue":"8","key":"6714_CR10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","volume":"116","author":"V Karantalis","year":"2015","unstructured":"Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116(8):1413\u201330.","journal-title":"Circ Res"},{"issue":"3","key":"6714_CR11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00019.2015","volume":"96","author":"S Golpanian","year":"2016","unstructured":"Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016;96(3):1127\u201368.","journal-title":"Physiol Rev"},{"issue":"1","key":"6714_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11373-007-9207-x","volume":"15","author":"J Guo","year":"2008","unstructured":"Guo J, Lin G, Bao C, Hu Z, Chu H, Hu M. Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction. J Biomed Sci. 2008;15(1):89\u201397.","journal-title":"J Biomed Sci"},{"issue":"22","key":"6714_CR13","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.jacc.2016.09.925","volume":"68","author":"S Kulandavelu","year":"2016","unstructured":"Kulandavelu S, Karantalis V, Fritsch J, Hatzistergos KE, Loescher VY, McCall F, et al. Pim1 kinase overexpression enhances ckit\u00a0+\u00a0Cardiac stem cell cardiac repair following myocardial infarction in swine. J Am Coll Cardiol. 2016;68(22):2454\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"6714_CR14","doi-asserted-by":"crossref","unstructured":"Chen L, Zhang Y, Tao L, Yang Z, Wang L. Mesenchymal stem cells with eNOS over-expression enhance cardiac repair in rats with myocardial infarction. Cardiovasc Drugs Ther. 2017;31, this issue.","DOI":"10.1007\/s10557-016-6704-z"},{"issue":"5","key":"6714_CR15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI9323","volume":"106","author":"P Varghese","year":"2000","unstructured":"Varghese P, Harrison RW, Lofthouse RA, Georgakopoulos D, Berkowitz DE, Hare JM. Beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility. J Clin Invest. 2000;106(5):697\u2013703.","journal-title":"J Clin Invest"},{"issue":"20","key":"6714_CR16","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMe048269","volume":"351","author":"JM Hare","year":"2004","unstructured":"Hare JM. Nitroso-redox balance in the cardiovascular system. New Engl J Med. 2004;351(20):2112\u20134.","journal-title":"New Engl J Med"},{"issue":"6 Pt 2","key":"6714_CR17","first-page":"H2646","volume":"271","author":"JF Keaney Jr","year":"1996","unstructured":"Keaney Jr JF, Hare JM, Balligand JL, Loscalzo J, Smith TW, Colucci WS. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. Am J Phys. 1996;271(6 Pt 2):H2646\u201352.","journal-title":"Am J Phys"},{"issue":"14","key":"6714_CR18","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000143232.67642.7A","volume":"110","author":"U Landmesser","year":"2004","unstructured":"Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation. 2004;110(14):1933\u20139.","journal-title":"Circulation"},{"issue":"9","key":"6714_CR19","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.RES.0000126497.38281.23","volume":"94","author":"S Janssens","year":"2004","unstructured":"Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res. 2004;94(9):1256\u201362.","journal-title":"Circ Res"},{"issue":"7","key":"6714_CR20","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s11033-009-9879-6","volume":"37","author":"LL Chen","year":"2010","unstructured":"Chen LL, Zhu TB, Yin H, Huang J, Wang LS, Cao KJ, et al. Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation. Mol Biol Rep. 2010;37(7):3067\u201372.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"6714_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.carpath.2007.02.007","volume":"16","author":"LL Chen","year":"2007","unstructured":"Chen LL, Yin H, Huang J. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis. Cardiovasc Pathol. 2007;16(4):221\u201330.","journal-title":"Cardiovasc Pathol"},{"issue":"12","key":"6714_CR22","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1172\/JCI119868","volume":"100","author":"A Papapetropoulos","year":"1997","unstructured":"Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997;100(12):3131\u20139.","journal-title":"J Clin Invest"},{"issue":"7","key":"6714_CR23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.RES.0000243989.46006.b9","volume":"99","author":"S Ahmad","year":"2006","unstructured":"Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T, et al. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res. 2006;99(7):715\u201322.","journal-title":"Circ Res"},{"issue":"6","key":"6714_CR24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Med. 2003;9(6):677\u201384.","journal-title":"Nature Med"},{"issue":"18","key":"6714_CR25","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1089\/ars.2014.5856","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim JH, Lee KS, Lee DK, Kim J, Kwak SN, Ha KS, et al. Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1\/vascular endothelial growth factor axis by targeting cullin 3. Antioxid Redox Signal. 2014;21(18):2469\u201382.","journal-title":"Antioxid Redox Signal"},{"issue":"15","key":"6714_CR26","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1073\/pnas.0901043106","volume":"106","author":"B Lima","year":"2009","unstructured":"Lima B, Lam GK, Xie L, Diesen DL, Villamizar N, Nienaber J, et al. Endogenous S-nitrosothiols protect against myocardial injury. Proc Nat Ac Sci USA. 2009;106(15):6297\u2013302.","journal-title":"Proc Nat Ac Sci USA"},{"key":"6714_CR27","doi-asserted-by":"crossref","unstructured":"Hatzistergos KE, Paulino EC, Dulce RA, Takeuchi LM, Bellio MA, Kulandavelu S, et al. S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction. J Am Heart Ass. 2015;4(7).","DOI":"10.1161\/JAHA.115.001974"},{"issue":"8","key":"6714_CR28","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1073\/pnas.1220185110","volume":"110","author":"SA Gomes","year":"2013","unstructured":"Gomes SA, Rangel EB, Premer C, Dulce RA, Cao Y, Florea V, et al. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells. Proc Nat Ac Sci USA. 2013;110(8):2834\u20139.","journal-title":"Proc Nat Ac Sci USA"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-017-6714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-017-6714-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-017-6714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T11:05:06Z","timestamp":1498388706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-017-6714-5"}},"subtitle":["Editorial to: \u201cMesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction\u201d by Leilei Chen et al."],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["6714"],"URL":"https:\/\/doi.org\/10.1007\/s10557-017-6714-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}